CYP2C192 Polymorphism in Chilean Patients with In-Stent Restenosis Development and Controls

Table 2

Angiographic characteristics of the study group according to the development of in-stent restenosis.

Variable	Patients with restenosis	Controls	value
	Lesion
Acute (%)	38.8	55.6	0.04
Chronic (%)	61.2	44.4
Diameter (mm)	3.0 ± 0.45	2.9 ± 0.3	0.95
Length (mm)	21.5 ± 5.4	21.4 ± 5.4	0.92
Lesion vessel (%)
LMCA	1.3	1	—
LAD	58.7	49	—
CX	13.3	20.4	—
RCA	26.7	29.6	—
Stent type (%)
DES	13	27.7	0.02
BMS	87	72.3

LMCA: left main coronary artery; LAD: left anterior descending artery; CX: circumflex artery; RCA: right coronary artery; BMS: bare-metal stent; DES: drug-eluting stent.